| |
| |
|
| Insider
Information: |
Rubinfeld Joseph |
| Relationship: |
Director |
| City: |
Dublin |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
3,499,390 |
|
|
Indirect Shares
|
49,000 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,548,390 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Astex Pharmaceuticals Inc |
ASTX |
Director |
2004-03-09 |
1,442,890 |
2004-03-09 |
49,000 |
Premium* |
|
|
Amarantus Biosciences Inc |
AMBS |
Director |
2014-12-08 |
2,056,500 |
2014-12-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMBS |
Amarantus Biosciences Inc |
Director |
– • – |
2014-12-08 |
4 |
A |
$0.09 |
$9,914 |
D/D |
116,500 |
2,056,500 |
0 |
- |
|
| AMBS |
Amarantus Biosciences Inc |
Director |
– • – |
2014-12-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,940,000 |
|
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
Director |
– • – |
2004-03-09 |
4 |
OE |
$3.40 |
$40,253 |
D/D |
11,839 |
1,442,890 |
|
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
Director |
– • – |
2004-01-08 |
4 |
OE |
$3.02 |
$86,149 |
D/D |
23,933 |
1,431,051 |
|
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
Director |
– • – |
2004-01-08 |
4 |
D |
$11.86 |
$86,115 |
D/D |
(7,261) |
1,407,118 |
|
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
President/CEO |
• • – |
2003-12-31 |
4 |
OE |
$3.40 |
$129,149 |
D/D |
22,506 |
1,414,379 |
|
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
President/CEO |
• • – |
2003-12-31 |
4 |
D |
$11.00 |
$129,129 |
D/D |
(11,739) |
1,391,873 |
|
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
President/CEO |
• • – |
2003-12-09 |
4 |
OE |
$3.40 |
$190,904 |
D/D |
50,266 |
1,403,612 |
|
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
President/CEO |
• • – |
2003-12-09 |
4 |
D |
$10.69 |
$190,891 |
D/D |
(17,857) |
1,353,346 |
|
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
officerTitle |
• • – |
2003-08-19 |
4 |
B |
$4.45 |
$6,675 |
D/D |
1,500 |
1,371,203 |
2.81 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
officerTitle |
• • – |
2003-08-18 |
4 |
B |
$4.67 |
$16,345 |
D/D |
3,500 |
1,369,703 |
2.81 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
